What Is Mycotoxin?

Mycotoxins are toxic chemical compounds that certain mold species produce as secondary metabolites — substances not essential for basic mold growth and reproduction but produced under specific environmental conditions. The term comes from Greek "mykes" (fungus) and "toxikon" (poison). Not all molds produce mycotoxins, and among those that can, production is not constant or guaranteed — it depends on substrate, temperature, competing organisms, and other factors.

The mycotoxins of greatest concern in indoor environments are trichothecenes (produced by Stachybotrys chartarum and some Fusarium species), aflatoxins (Aspergillus flavus and A. parasiticus), and ochratoxin A (some Aspergillus and Penicillium species). Each has a different mechanism of toxicity and target organ. Trichothecenes inhibit protein synthesis and can affect the immune system; aflatoxins are potent liver carcinogens; ochratoxin A is nephrotoxic (kidney-damaging).

The clinical significance of mycotoxin exposure from water-damaged buildings remains an active area of scientific debate. Some researchers and physicians, particularly in the functional medicine community, attribute a wide range of chronic symptoms (fatigue, cognitive difficulties, pain) to building-associated mycotoxin exposure. Mainstream occupational medicine and toxicology takes a more cautious position: while mycotoxin exposure can certainly cause illness at high doses, evidence for chronic low-dose building-associated illness is less clear.

What is not debated: buildings with severe water damage and Stachybotrys growth should be professionally remediated, and occupants with unexplained chronic symptoms in a building with known mold damage deserve thorough environmental and medical evaluation. Mycotoxin testing of urine is commercially available but has significant interpretive limitations — positive results require expert interpretation by a physician familiar with environmental illness.